home / stock / ktra / ktra news


KTRA News and Press, Kintara Therapeutics Inc Com

Stock Information

Company Name: Kintara Therapeutics Inc Com
Stock Symbol: KTRA
Market: NASDAQ
Website: kintara.com

Menu

KTRA KTRA Quote KTRA Short KTRA News KTRA Articles KTRA Message Board
Get KTRA Alerts

News, Short Squeeze, Breakout and More Instantly...

KTRA - TuHURA Biosciences Enters into Exclusivity and Right of First Offer Agreement for Kineta, Inc.'s KVA12123 Novel anti-VISTA Checkpoint Inhibitor

TuHURA Biosciences Enters into Exclusivity and Right of First Offer Agreement for Kineta, Inc.'s KVA12123 Novel anti-VISTA Checkpoint Inhibitor PR Newswire KVA12123 is a rationally targeted, anti-VISTA antibody checkpoint inhibitor to reverse VISTA immune suppression and remod...

KTRA - Kintara Therapeutics and TuHURA Biosciences Provide Update on Recent Corporate and Clinical Advancements and Outline Near Term Milestones

Kintara Therapeutics and TuHURA Biosciences Provide Update on Recent Corporate and Clinical Advancements and Outline Near Term Milestones PR Newswire SAN DIEGO , July 1, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara"), a biopharmaceutic...

KTRA - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

2024-06-21 07:52:21 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning! Moving stocks are a bankruptcy filing, regulator app...

KTRA - US Companies Moving the Markets, Morning edition
Tue, Jun 04, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States SOBR Safe Inc. (SOBR) rose 115.1% to $0.5667 on volume of 77,631,052 shares MicroAlgo Inc. (MLGO) rose 284.0% to $5.99 on volume of 40,752,997 shares Crown Electrokinetics Corp. (CRKN) fell 13.8% to $0.1016 on volume of 28,247,104 sha...

KTRA - TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC)

TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) PR Newswire TuHURA's l...

KTRA - US Companies Moving the Markets, Morning edition
Thu, May 30, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Cue Health Inc. (HLTH) rose 137.4% to $0.1301 on volume of 266,617,329 shares Greenwave Technology Solutions Inc. (GWAV) fell 6.7% to $0.0461 on volume of 113,465,031 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 20.4% t...

KTRA - US Companies Moving the Markets, Evening edition
Wed, May 29, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) fell 37.2% to $0.0494 on volume of 615,002,672 shares Innovative Eyewear Inc. (LUCY) rose 131.5% to $0.949 on volume of 566,381,896 shares Faraday Future Intelligent Electric Inc. (FFIE) fell...

KTRA - US Companies Moving the Markets, Morning edition
Mon, May 20, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Crown Electrokinetics Corp. (CRKN) rose 37.1% to $0.2344 on volume of 300,511,226 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 78.2% to $1.835 on volume of 218,102,513 shares Greenwave Technology Solutions Inc. (GWAV) r...

KTRA - Kintara Therapeutics GAAP EPS of -$0.05

2024-05-15 09:47:17 ET More on Kintara Therapeutics Kintara to merge with TuHURA Bio in all-stock deal Financial information for Kintara Therapeutics Read the full article on Seeking Alpha For further details see: Kintara Therapeutics GAAP EPS of -$0.05

KTRA - Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results

Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results PR Newswire SAN DIEGO , May 14, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of n...

Next 10